Epidemiology, treatment and outcomes of anemia in premature newborn babies in Centre Hospitalierd’Essos, Yaounde, Cameroon.
Résumé
Abstract IntroductionAt birth, all newborns experience a decrease in hemoglobin levels; this decrease is more emphasized in premature babies. The objective of this work was to study the epidemiological, therapeutic and outcomesof anemia amongst preterm birthsin a reference hospital in Cameroon.MethodologyThis was a two-year retrospective cohort study (January 1, 2016 to December 31, 2017). All premature infants with a hemoglobin level below 14g/dl at a given time of hospitalization were included in the study; these were divided into two groups: group A transfusion recipients and group B non-transfusion recipients. The main measurements were prevalence of premature anemia and incidence of blood transfusion, features of population and outcomes.Results142 cases of anemic premature infants (56.34% female) with a mean gestationalage of 31.58 +/- 2.81 weeks of amenorrhea and a mean birth weight of 1652.78 +/- 514.77g were included in the study. The prevalence of premature anemia was 24.2%. Blood transfusion was the most widely used therapeutic method with an incidence of 57.75%, follow by iron (56.34%) and Erythropoietin (EPO) (4.93%). Out of the 142 cases recruited, 82 were in the transfusion group and 60 in the non-transfusion group. Predictive factors of blood transfusion were gestational age (33 weeks), birth weight (less than 1500g) and non-administration of vitamin K and Uvesterol®. Premature infants transfused compared to those not transfused had a longer duration of hospitalisation (p<0,001) and more complications during hospitalization (p<0,001). The overall mortality rate was 21.13% with a higher rate in the transfused group (12,68% vs. 8, 45%) but no significant (p=0.96).ConclusionAnemia of prematurity isa frequent pathology in this setting, with Blood transfusion as main therapy. Administration of vitamin K and Uvesterol®should be ensured in this population while advocating for the access to EPO.
Citer ce document
Accès au document
Voir sur le dépôt sourceCe document est hébergé sur son dépôt institutionnel d'origine.
Statistiques
Consultations : 1
Téléchargements : 0